Skip to content.
Skip to navigation
Logo
GreaterCleveland
.localhealth.info
Personal tools
Log in
Contact
Join
Home
»
Contributors
»
admin
»
FDA MedWatch
Search Site
Advanced Search…
Home
About
Locate Services
Data Help
News Desk
Events
Keywords
Make a Bar Chart
Contributors
admin
Site Survey
FDA MedWatch
AHRQ QualityTools
HIV/AIDS Prevention
Food and Drug Administration Press Releases
Health Diparities Blog
MMWR
Plain Dealer Health Blog
Social & Behavioral Science
Cancer Articles
EurekAlert! Earth Sciences
EurekAlert! Education
EurekAlert! Medicine and Health
EurekAlert! Infectious and Emerging Diseases
Noteworthy:
Fewer Cleveland residents tested positive for HIV/AIDS in 2007
25-Year Trend in Heart Deaths Shows Steady Decline, Disparity
Medicaid coverage expansion benefits additional Ohioans and pregnant women
Rapid increase in syphilis leads to joint public health action
New cases of HIV/AIDS increased 57% among Cuyahoga County youth
More…
Document Actions
FDA MedWatch
Posted by
admin
—
last modified
December 21, 2007
Professional and consumer alerts
RSS feed provided by:
FDA MedWatch
Tumor necrosis factor-α blockers (TNF blockers), Cimzia (certolizumab pegol), Enbrel (etanercept), Humira (adalimumab), and Remicade (infliximab)
September 2008 Patient Safety News
Pacific Consolidated brand Mobile Oxygen Storage Tank
Tysabri (natalizumab)
Ezetimibe/Simvastatin (Vytorin); Simvastatin (Zocor); and Ezetimibe (Zetia)
Byetta (exenatide)
July 2008 Monthly Safety Labeling
Boston Scientific NexStent Monorail, NexStent Carotid Stent and Monorail Delivery System
Vivitrol (naltrexone)
Keywords:
Consumer Safety
,
Drugs
LocalHealth is a network of health information users hosted by the
Department of Epidemiology and Biostatistics
at
Case Western Reserve University School of Medicine
, and developed in association with our primary partners:
Website by LocalHealth.
Powered by Plone, the Open Source Content Management System
Copyright © 2003-
2008